On a Monday in April 2026, a landmark medical event unfolded in Beijing’s Fengtai District, bringing cutting-edge domestic neurotechnology into the global spotlight. Hundreds of neurological and medical experts from across the country tuned into a public livestream broadcast from Beijing Tiantan Hospital, where surgeons successfully deployed Beinao-1 — China’s independently developed high-performance semi-invasive implantable brain-computer interface (BCI) system — during a live surgical procedure.
The livestream delivered crisp, high-definition footage of every critical stage of the operation, allowing the gathered observing experts to track and deliberate on key technical decisions in real time. Core points of discussion among the professional audience included the nuanced selection of surgical access routes tailored to the patient’s anatomy, the precise calibration of electrode implantation depth to maximize signal capture, and targeted strategies for debugging and stabilizing neural signal output after implantation.
This public demonstration marks a major milestone for China’s domestic BCI development, showcasing the maturity of locally built neurotechnology that can be integrated into routine clinical surgical practice. Unlike fully invasive BCI systems that require penetrating deep brain tissue, or non-invasive options that often suffer from weak, distorted signal quality, Beinao-1’s semi-invasive design strikes a carefully balanced middle ground, lowering surgical risk while maintaining high-fidelity neural signal capture — a key advantage for widespread clinical adoption. The livestreamed procedure also created an unprecedented opportunity for cross-institutional knowledge sharing, allowing hundreds of experts nationwide to observe and engage with the implementation of a new domestic BCI system without travel, accelerating the dissemination of cutting-edge neurotech surgical techniques across China’s medical community.